The team at Arnold & Porter is particularly well regarded for its expertise in the life sciences, pharmaceutical and technology sectors; major players from these industries - including those which operate at the crossroads, such as biotechs - form the core of the client base. Cartel investigations and follow-on damages claims are areas of strength. Niels Christian Ersbøll acts as head of the Brussels office, and is regularly supported on key competition mandates by international merger control expert Axel Gutermuth and French-qualified counsel Charlotte Simphal.
Legal 500 Editorial commentary
Key clients
- Boston Scientific Corporation
- BP
- Bristol-Myers Squibb
- Callaway Golf
- Cisco Systems
- Diageo Great Britain Limited
- European Federation of Pharmaceutical Industry Association (EFPIA)
- International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
- Mitsui OSK Lines
- Novo Nordisk
- Pfizer
- Samsung SDI
- Thermo Fisher Scientific
- Visa Inc.
- WM Morrison Supermarkets
- Curium Pharma
Work highlights
- Advising Pfizer on its $43bn acquisition of Seagen.
- Advised Bristol Myers Squibb on its successful $4.1bn acquisition of Turning Point Therapeutics.
- Advised Boston Scientific on its successful $615m acquisition of Apollo Endosurgery.
Practice head
The lawyer(s) leading their teams.
Niels Christian Ersbøll